US biotech firm reports 95% dodo genome analysis, eyes possible revival of extinct bird
Colossal Biosciences, a US biotechnology company, is working to bring back the extinct dodo through gene-editing techniques. Using its AI platform GenoMorph, the firm has identified key genetic traits relevant to the project. Analysis of the dodo genome is about 95% complete, and the effort is reported to be progressing as planned. The company has not announced when a living dodo might be produced. The project is framed as part of a broader push to reverse extinctions caused by human activity.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in